Drug discovery and development has always been subject to a large degree of chance and serendipity. Now, artificial intelligence (AI) is promising to substantially boost the odds of identifying new ...
Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results